Management of prehypertension

Current status and future strategies

Hiroyuki Sasamura, Hiroshi Itoh, Stevo Julius

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Prehypertension is known to be a risk factor for hypertension and cardiovascular disease. If prehypertension is left untreated, the blood pressure continues to increase due to multiple accelerators which facilitate the development of hypertension. Studies using animal models of hypertension suggested that interruption of these mechanisms by transient inhibition of the renin-angiotensin system (RAS) attenuates the development of hypertension. The TROPHY study provided clinical evidence that pharmacological intervention in the prehypertensive stage may suppress subsequent development of hypertension. Recently, we reported that high dose angiotensin inhibition in spontaneously hypertensive rats (SHR) with established hypertension caused a significant regression of hypertension, and we have started a prospective, multi-center clinical study (STAR CAST study) to examine if regression from hypertension back to prehypertension may also be feasible in humans. Since prehypertension is increasingly recognized as an important public health issue, further studies to assess strategies for attenuating the progression from prehypertension to hypertension are required.

Original languageEnglish
Pages (from-to)118-124
Number of pages7
JournalCurrent Hypertension Reviews
Volume7
Issue number2
Publication statusPublished - 2011 Sep

Fingerprint

Prehypertension
Hypertension
Angiotensins
Inbred SHR Rats
Renin-Angiotensin System
Cardiovascular Diseases
Animal Models
Public Health
Pharmacology
Blood Pressure

Keywords

  • High-normal blood pressure
  • Pharmacological therapy
  • Prehypertension
  • Prevention
  • Regression

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Management of prehypertension : Current status and future strategies. / Sasamura, Hiroyuki; Itoh, Hiroshi; Julius, Stevo.

In: Current Hypertension Reviews, Vol. 7, No. 2, 09.2011, p. 118-124.

Research output: Contribution to journalArticle

Sasamura, Hiroyuki ; Itoh, Hiroshi ; Julius, Stevo. / Management of prehypertension : Current status and future strategies. In: Current Hypertension Reviews. 2011 ; Vol. 7, No. 2. pp. 118-124.
@article{314dbcd159ee4dd19e38f3f71f37e573,
title = "Management of prehypertension: Current status and future strategies",
abstract = "Prehypertension is known to be a risk factor for hypertension and cardiovascular disease. If prehypertension is left untreated, the blood pressure continues to increase due to multiple accelerators which facilitate the development of hypertension. Studies using animal models of hypertension suggested that interruption of these mechanisms by transient inhibition of the renin-angiotensin system (RAS) attenuates the development of hypertension. The TROPHY study provided clinical evidence that pharmacological intervention in the prehypertensive stage may suppress subsequent development of hypertension. Recently, we reported that high dose angiotensin inhibition in spontaneously hypertensive rats (SHR) with established hypertension caused a significant regression of hypertension, and we have started a prospective, multi-center clinical study (STAR CAST study) to examine if regression from hypertension back to prehypertension may also be feasible in humans. Since prehypertension is increasingly recognized as an important public health issue, further studies to assess strategies for attenuating the progression from prehypertension to hypertension are required.",
keywords = "High-normal blood pressure, Pharmacological therapy, Prehypertension, Prevention, Regression",
author = "Hiroyuki Sasamura and Hiroshi Itoh and Stevo Julius",
year = "2011",
month = "9",
language = "English",
volume = "7",
pages = "118--124",
journal = "Current Medical Imaging Reviews",
issn = "1573-4056",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Management of prehypertension

T2 - Current status and future strategies

AU - Sasamura, Hiroyuki

AU - Itoh, Hiroshi

AU - Julius, Stevo

PY - 2011/9

Y1 - 2011/9

N2 - Prehypertension is known to be a risk factor for hypertension and cardiovascular disease. If prehypertension is left untreated, the blood pressure continues to increase due to multiple accelerators which facilitate the development of hypertension. Studies using animal models of hypertension suggested that interruption of these mechanisms by transient inhibition of the renin-angiotensin system (RAS) attenuates the development of hypertension. The TROPHY study provided clinical evidence that pharmacological intervention in the prehypertensive stage may suppress subsequent development of hypertension. Recently, we reported that high dose angiotensin inhibition in spontaneously hypertensive rats (SHR) with established hypertension caused a significant regression of hypertension, and we have started a prospective, multi-center clinical study (STAR CAST study) to examine if regression from hypertension back to prehypertension may also be feasible in humans. Since prehypertension is increasingly recognized as an important public health issue, further studies to assess strategies for attenuating the progression from prehypertension to hypertension are required.

AB - Prehypertension is known to be a risk factor for hypertension and cardiovascular disease. If prehypertension is left untreated, the blood pressure continues to increase due to multiple accelerators which facilitate the development of hypertension. Studies using animal models of hypertension suggested that interruption of these mechanisms by transient inhibition of the renin-angiotensin system (RAS) attenuates the development of hypertension. The TROPHY study provided clinical evidence that pharmacological intervention in the prehypertensive stage may suppress subsequent development of hypertension. Recently, we reported that high dose angiotensin inhibition in spontaneously hypertensive rats (SHR) with established hypertension caused a significant regression of hypertension, and we have started a prospective, multi-center clinical study (STAR CAST study) to examine if regression from hypertension back to prehypertension may also be feasible in humans. Since prehypertension is increasingly recognized as an important public health issue, further studies to assess strategies for attenuating the progression from prehypertension to hypertension are required.

KW - High-normal blood pressure

KW - Pharmacological therapy

KW - Prehypertension

KW - Prevention

KW - Regression

UR - http://www.scopus.com/inward/record.url?scp=80053462975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053462975&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 118

EP - 124

JO - Current Medical Imaging Reviews

JF - Current Medical Imaging Reviews

SN - 1573-4056

IS - 2

ER -